{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:14:49Z","timestamp":1787242489848,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The concentrations of complement proteins (adipsin, C3a, and C5a) and soluble endoglin (sENG) in the plasma were measured in this study, and their value as early-pregnancy predictors and potential diagnostic marker of preeclampsia was assessed, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Design<\/jats:title>\n                    <jats:p>Plasma samples were obtained from healthy and preeclampsia pregnant women before delivery for a cross-sectional study. Plasma samples were collected from healthy and preeclampsia pregnant women throughout pregnancy and postpartum for a follow-up study. Enzyme-linked immunosorbent assays were used to detect plasma levels of several complement proteins (adipsin, C3a, and C5a) and sENG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The plasma levels of adipsin, C5a, and sENG were significantly increased before delivery in pregnant women with preeclampsia. During pregnancy, the plasma adipsin, C5a, and sENG levels were increased from the third trimester in healthy pregnant women; plasma adipsin levels remained stable after delivery, while C3a levels increased in the second trimester and remained stable afterward. Furthermore, levels of adipsin, C5a, and sENG were higher in preeclampsia patients at different stages of pregnancy; the C3a level presents a similar change and no difference was found in the third trimester. In the first trimester, receiver-operating curve (ROC) curve analysis showed that adipsin (AUC, 0.83 \u00b1 0.06,\n                      <jats:italic>P<\/jats:italic>\n                      =0.001) and sENG (AUC, 0.74 \u00b1 0.09,\n                      <jats:italic>P<\/jats:italic>\n                      =0.021) presented high value as predictors of early pregnancy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adipsin is likely a novel plasma biomarker to monitor the increased risk of preeclampsia in early pregnancy. Moreover, the increased plasma levels of adipsin, C5a, and sENG before delivery may be associated with preeclampsia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2021.702385","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T03:12:55Z","timestamp":1633317175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy"],"prefix":"10.3389","volume":"12","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-Eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6564","article-title":"Pre-Eclampsia Rates in the United States, 1980-2010: Age-Period-Cohort Analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The Global Impact of Pre-Eclampsia and Eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2008.10.011","article-title":"Factors Involved in Regulating Trophoblast Fusion: Potential Role in the Development of Preeclampsia","volume":"30","author":"Gauster","year":"2009","journal-title":"Placenta"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.03.010","article-title":"Dysregulated Complement Activation as a Common Pathway of Injury in Preeclampsia and Other Pregnancy Complications","volume":"31","author":"Lynch","year":"2010","journal-title":"Placenta"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ni1317","article-title":"Mother's Little Helpers: Mechanisms of Maternal-Fetal Tolerance","volume":"7","author":"Trowsdale","year":"2006","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061022","article-title":"Complement Activation Induces Dysregulation of Angiogenic Factors and Causes Fetal Rejection and Growth Restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)50409-4","article-title":"Human Adipsin is Identical to Complement Factor D and is Expressed at High Levels in Adipose Tissue","volume":"267","author":"White","year":"1992","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/srep20073","article-title":"Serum Adipsin Levels Throughout Normal Pregnancy and Preeclampsia","volume":"6","author":"Poveda","year":"2016","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02688","article-title":"Elevation of Urinary Adipsin in Preeclampsia: Correlation With Urine Protein Concentration and the Potential Use for a Rapid Diagnostic Test","volume":"64","author":"Wang","year":"2014","journal-title":"Hypertension"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: A Key System for Immune Surveillance and Homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement Activation and Inhibition: A Delicate Balance","volume":"30","author":"Sjoberg","year":"2009","journal-title":"Trends Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500072722","article-title":"Normal Pregnancy Is Characterized by Systemic Activation of the Complement System","volume":"17","author":"Richani","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0020-7292(92)90784-G","article-title":"Complement, Neutrophil, and Macrophage Activation in Women With Severe Preeclampsia and the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count","volume":"79","author":"Haeger","year":"1992","journal-title":"Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the Complement System in Normal Pregnancy and Preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2009.02473.x","article-title":"The Interrelationship of Complement-Activation Fragments and Angiogenesis-Related Factors in Early Pregnancy and Their Association With Pre-Eclampsia","volume":"117","author":"Lynch","year":"2010","journal-title":"BJOG"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3109\/14767050903301009","article-title":"Preeclampsia and Pregnancies With Small-for-Gestational Age Neonates Have Different Profiles of Complement Split Products","volume":"23","author":"Soto","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejogrb.2014.09.027","article-title":"Abnormal Blood Biomarkers in Early Pregnancy are Associated With Preeclampsia: A Meta-Analysis","volume":"182","author":"Allen","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm1429","article-title":"Soluble Endoglin Contributes to the Pathogenesis of Preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17189","article-title":"Excess Placental Soluble Fms-Like Tyrosine Kinase 1 (Sflt1) may Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13348","article-title":"Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes","volume":"74","author":"Leanos-Miranda","year":"2019","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","author":"Roberts","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201000123","article-title":"Proteins in Leaked Amniotic Fluid as Biomarkers Diagnostic for Prelabor Rupture of Membranes","volume":"5","author":"Wang","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer's Disease: Current Status and Prospects for the Future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, Biomarkers, Syncytiotrophoblast Stress, and Placental Capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.placenta.2019.02.014","article-title":"Plasma Concentrations of Soluble Endoglin in the Maternal Circulation are Associated With Maternal Vascular Malperfusion Lesions in the Placenta of Women With Preeclampsia","volume":"78","author":"Schmella","year":"2019","journal-title":"Placenta"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/14767050802034545","article-title":"The Change in Concentrations of Angiogenic and Anti-Angiogenic Factors in Maternal Plasma Between the First and Second Trimesters in Risk Assessment for the Subsequent Development of Preeclampsia and Small-for-Gestational Age","volume":"21","author":"Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.915777","article-title":"Serum Levels of Complement Factors C1q, Bb, and H in Normal Pregnancy and Severe Pre-Eclampsia","volume":"25","author":"Jia","year":"2019","journal-title":"Med Sci Monit"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative Complement Pathway Activation Fragment Bb in Early Pregnancy as a Predictor of Preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12349","article-title":"Urinary Excretion of C5b-9 is Associated With the Anti-Angiogenic State in Severe Preeclampsia","volume":"73","author":"Guseh","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molimm.2020.03.021","article-title":"Dysregulation of Complement System During Pregnancy in Patients With Preeclampsia: A Prospective Study","volume":"122","author":"He","year":"2020","journal-title":"Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12586","article-title":"Complement Component C1q as Potential Diagnostic But Not Predictive Marker of Preeclampsia","volume":"76","author":"Agostinis","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12541","article-title":"Expression of the Complement System's Activation Factors in Plasma of Patients With Early\/Late-Onset Severe Pre-Eclampsia","volume":"76","author":"He","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jri.2014.12.002","article-title":"Complement Factor B Activation in Patients With Preeclampsia","volume":"109","author":"Velickovic","year":"2015","journal-title":"J Reprod Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/aji.12162","article-title":"Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia","volume":"71","author":"Hoffman","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1262\/jrd.10-036k","article-title":"Elevation of Adipsin, a Complement Activating Factor, in the Mouse Placenta During Spontaneous Abortion","volume":"56","author":"Takeshita","year":"2010","journal-title":"J Reprod Dev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","article-title":"Adipsin Is an Adipokine That Improves Beta Cell Function in Diabetes","volume":"158","author":"Lo","year":"2014","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00514.x","article-title":"Plasma Acylation Stimulating Protein, Adipsin and Lipids in Non-Obese and Obese Populations","volume":"29","author":"Maslowska","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3928","article-title":"Plasma Complement Components and Activation Fragments: Associations With Age-Related Macular Degeneration Genotypes and Phenotypes","volume":"50","author":"Reynolds","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200305000-00020","article-title":"Maternal Body Mass Index and the Risk of Preeclampsia: A Systematic Overview","volume":"14","author":"O'Brien","year":"2003","journal-title":"Epidemiology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2016.1140738","article-title":"The Association Between Body Mass Index and Preeclampsia: A Meta-Analysis","volume":"29","author":"Poorolajal","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0223888","DOI":"10.1371\/journal.pone.0223888","article-title":"Increased BMI has a Linear Association With Late-Onset Preeclampsia: A Population-Based Study","volume":"14","author":"Robillard","year":"2019","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2012.11.006","article-title":"Elevated Complement Factor C5a in Maternal and Umbilical Cord Plasma in Preeclampsia","volume":"97","author":"Denny","year":"2013","journal-title":"J Reprod Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2012.01158.x","article-title":"Biomarkers of Coagulation, Inflammation, and Angiogenesis Are Independently Associated With Preeclampsia","volume":"68","author":"Boij","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78952-1_6","article-title":"Interaction Between the Coagulation and Complement System","volume":"632","author":"Amara","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217991110","article-title":"Targeting Complement Component 5a Promotes Vascular Integrity and Limits Airway Remodeling","volume":"110","author":"Khan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in Inflammatory Responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e13202","DOI":"10.1111\/aji.13202","article-title":"Normal Range of Complement Components During Pregnancy: A Prospective Study","volume":"83","author":"He","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02084","article-title":"The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy","volume":"11","author":"Chighizola","year":"2020","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/0891693031000067322","article-title":"The Role of Complement in Pregnancy and Fetal Loss","volume":"36","author":"Girardi","year":"2003","journal-title":"Autoimmunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.702385\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T03:12:58Z","timestamp":1633317178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.702385\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2021.702385"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.702385","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"article-number":"702385"}}